Kevin is a principal within Deloitte Consulting’s Life Sciences Strategy & Analytics practice. He has more than 20 years of experience within the biopharmaceutical industry and his primary area of focus is research and development (R&D).
Kevin's client engagement experiences span across the R&D value chain. He has led both targeted and enterprise-wide R&D productivity efforts for many of the industry’s leading companies and his contributions encompass both strategy development and implementation. He is a frequent writer and speaker on R&D productivity, co-authors Deloitte’s annual study measuring the industry’s return on R&D investment, and manages Deloitte’s cross-company R&D CFO Forum.
Prior to joining Deloitte, Kevin worked for Wyeth as a biopharmaceutical research engineer supporting the discovery, development and commercialization of various monoclonal antibody conjugate and vaccine programs. He received a B.S. in Biochemical Engineering from Rutgers University, an M.S. in Chemical Engineering from Rutgers University, and an M.B.A. in Finance and Managerial Economics from the Kellogg School of Management at Northwestern University.